Physicians at the Icahn School of Medicine at Mount Sinai are calling for updates to a widely used system that grades side effects from cancer treatments, warning that current criteria may misclassify the severity of skin-related toxicities and limit consistency across clinical trials.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗